Cara | $8,000,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
Earlyasset | $2,000,000 | (Apr 2, 2026)
Certified by Founder
Lodge
ExcepGen
start up
United States
- San Francisco, CA
- 25/08/2023
- Unknown
- $4,000,000
ExcepGen is a venture-backed, early stage biotechnology company located in San Francisco. The company is focused on solving fundamental underlying problems in drug discovery and applying those solutions to create a new generation of therapeutics.
- Industry Biotechnology Research
- Website https://www.excepgen.com/
- LinkedIn https://www.linkedin.com/company/excepgen/about/
Related People
Thomas FolliardCo Founder
United States -
San Francisco, California
I am involved in a variety of activities and responsibilities having to do with making drugs easier to discover.
Specialties: foundational engineering of biology, next-generation drugs and drug discovery, starting organizations.
Sona(UK) | $45,000,000 | (Apr 2, 2026)
Variance | $21,500,000 | (Apr 2, 2026)
Linx Security | $50,000,000 | (Apr 2, 2026)
TippingPoint Biosciences | $4,500,000 | (Apr 2, 2026)
Quantcore | $3,318,962 | (Apr 2, 2026)
Whirl AI | $8,900,000 | (Apr 2, 2026)
Semarion | $3,800,000 | (Apr 2, 2026)
Via Separations | $36,000,000 | (Apr 2, 2026)
Stedi | $50,000,000 | (Mar 31, 2026)